Literature DB >> 28377476

Incidence and predictors of obstetric and fetal complications in women with structural heart disease.

Iris M van Hagen1, Jolien W Roos-Hesselink1,2, Valentina Donvito3, Csilla Liptai4, Marielle Morissens5, Daniel J Murphy6, Laura Galian7, Nooshin Mohd Bazargani8, Jérôme Cornette9, Roger Hall10, Mark R Johnson11.   

Abstract

OBJECTIVE: Women with cardiac disease becoming pregnant have an increased risk of obstetric and fetal events. The aim of this study was to study the incidence of events, to validate the modified WHO (mWHO) risk classification and to search for event-specific predictors.
METHODS: The Registry Of Pregnancy And Cardiac disease is a worldwide ongoing prospective registry that has enrolled 2742 pregnancies in women with known cardiac disease (mainly congenital and valvular disease) before pregnancy, from January 2008 up to April 2014.
RESULTS: Mean age was 28.2±5.5 years, 45% were nulliparous and 33.3% came from emerging countries. Obstetric events occurred in 231 pregnancies (8.4%). Fetal events occurred in 651 pregnancies (23.7%). The mWHO classification performed poorly in predicting obstetric (c-statistic=0.601) and fetal events (c-statistic=0.561). In multivariable analysis, aortic valve disease was associated with pre-eclampsia (OR=2.6, 95%CI=1.3 to 5.5). Congenital heart disease (CHD) was associated with spontaneous preterm birth (OR=1.8, 95%CI=1.2 to 2.7). Complex CHD was associated with small-for-gestational-age neonates (OR=2.3, 95%CI=1.5 to 3.5). Multiple gestation was the strongest predictor of fetal events: fetal/neonatal death (OR=6.4, 95%CI=2.5 to 16), spontaneous preterm birth (OR=5.3, 95%CI=2.5 to 11) and small-for-gestational age (OR=5.0, 95%CI=2.5 to 9.8).
CONCLUSION: The mWHO classification is not suitable for prediction of obstetric and fetal events in women with cardiac disease. Maternal complex CHD was independently associated with fetal growth restriction and aortic valve disease with pre-eclampsia, potentially offering an insight into the pathophysiology of these pregnancy complications. The increased rates of adverse obstetric and fetal outcomes in women with pre-existing heart disease should be highlighted during counselling. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Congenital heart disease; Prediction; Pregnancy; Valvular heart disease

Mesh:

Year:  2017        PMID: 28377476     DOI: 10.1136/heartjnl-2016-310644

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  8 in total

1.  Adverse Pregnancy Conditions Among Privately Insured Women With and Without Congenital Heart Defects.

Authors:  Karrie F Downing; Naomi K Tepper; Regina M Simeone; Elizabeth C Ailes; Michelle Gurvitz; Sheree L Boulet; Margaret A Honein; Penelope P Howards; Anne M Valente; Sherry L Farr
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-06-08

Review 2.  Valvular Heart Disease in Women, Differential Remodeling, and Response to New Therapies.

Authors:  Jaya Chandrasekhar; George Dangas; Roxana Mehran
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-09-11

3.  Validation of the Risk Score for Maternal Cardiac Complications in Women with Cardiac Disease in Pregnancy: A Retrospective Study.

Authors:  C N Sheela; Nekkilady Veni; Ponnusamy Vinotha; Selvam Sumithra
Journal:  J Obstet Gynaecol India       Date:  2019-04-22

Review 4.  Management of Women With Congenital or Inherited Cardiovascular Disease From Pre-Conception Through Pregnancy and Postpartum: JACC Focus Seminar 2/5.

Authors:  Kathryn J Lindley; C Noel Bairey Merz; Anita W Asgar; Natalie A Bello; Sonal Chandra; Melinda B Davis; Mardi Gomberg-Maitland; Martha Gulati; Lisa M Hollier; Eric V Krieger; Ki Park; Candice Silversides; Natasha K Wolfe; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2021-04-13       Impact factor: 24.094

5.  Younger Women Living with Chronic Disease: Comparative Challenges, Resiliencies, and Needs in Heart Disease and Breast Cancer.

Authors:  Jacqueline H J Kim; Brittany L Drake; Eynav E Accortt; Irene S Pollin; C Noel Bairey Merz; Annette L Stanton
Journal:  J Womens Health (Larchmt)       Date:  2021-01-11       Impact factor: 3.017

6.  Predicting the Risk of Adverse Events in Pregnant Women With Congenital Heart Disease.

Authors:  Ran Chu; Wei Chen; Guangmin Song; Shu Yao; Lin Xie; Li Song; Yue Zhang; Lijun Chen; Xiangli Zhang; Yuyan Ma; Xia Luo; Yuan Liu; Ping Sun; Shuquan Zhang; Yan Fang; Taotao Dong; Qing Zhang; Jin Peng; Lu Zhang; Yuan Wei; Wenxia Zhang; Xuantao Su; Xu Qiao; Kun Song; Xingsheng Yang; Beihua Kong
Journal:  J Am Heart Assoc       Date:  2020-07-14       Impact factor: 5.501

Review 7.  Pregnancy in congenital heart disease: risk prediction and counselling.

Authors:  Iris M van Hagen; Jolien W Roos-Hesselink
Journal:  Heart       Date:  2020-07-01       Impact factor: 5.994

8.  Predictors of maternal and neonatal complications in women with severe valvular heart disease during pregnancy in Tunisia: a retrospective cohort study.

Authors:  Rania Hammami; Mohamed Ali Ibn Hadj; Yosra Mejdoub; Amine Bahloul; Selma Charfeddine; Leila Abid; Samir Kammoun; Abdallah Dammak; Kais Chaabene
Journal:  BMC Pregnancy Childbirth       Date:  2021-12-08       Impact factor: 3.007

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.